Provided by Tiger Trade Technology Pte. Ltd.

iShares Genomics Immunology and Healthcare ETF

39.67
-0.4100-1.02%
Post-market: 39.00-0.6700-1.69%17:02 EDT
Volume:143.91K
Turnover:5.68M
Market Cap:247.94M
PE:- -
High:39.84
Open:39.76
Low:39.00
Close:40.08
52wk High:40.86
52wk Low:22.12
Shares:6.25M
Float Shares:6.25M
Volume Ratio:1.29
T/O Rate:2.30%
Dividend:0.28
Dividend Rate:0.71%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Option Focus | Moderna's $525K Bear Call Spread and $1.67M Long-Dated Put Buy Reveal Institutions Bracing for a Major Downside Move

Option Witch
·
Aug 20

Press Release: Vertex Resource Group Ltd. Reports Second Quarter 2026 Results

Dow Jones
·
Aug 20

NASD Most Active Issues

Dow Jones
·
Aug 20

One Great Chart: Moderna Surge Makes S&P History

Dow Jones
·
Aug 20

Moderna price target raised to $89 from $39 at Morgan Stanley

TIPRANKS
·
Aug 20

Crinetics Faces Shareholder Challenges to Vertex Merger Deal

TIPRANKS
·
Aug 20

Moderna Inc. Stock Rallies 177.0%, Outperforms Peers

Dow Jones
·
Aug 20

Moderna's Cancer-Vaccine Breakthrough Drives Broad Biopharma Stock Rally

Dow Jones
·
Aug 20

Moderna Closes up Nearly 177%, Best Performer in the S&P 500 Today

Dow Jones
·
Aug 20

Vertex Pharmaceuticals Inc Stock (VRTX) Closed Up by 4.48% on Aug 19: Drivers Behind the Movement

TradingKey
·
Aug 20

US Stocks Close: Dow Rises Over 120 Points, SOX Drops 2%; Memory Stocks Lead Losses, SanDisk Falls 3.5%, Moderna Surges 177%

TradingKey
·
Aug 20

US Closing Bell | Unable to generate due to lack of news data

US Closing Bell
·
Aug 20

Moderna Shares More than Double on Success of mRNA Cancer Vaccine

Dow Jones
·
Aug 20

Moderna Raised to Outperform from Market Perform by William Blair

Dow Jones
·
Aug 20

Scorpion Capital Says it is Short Twist Bioscience

Reuters
·
Aug 20

Scorpion Capital: We are Short Twist Biosciences

THOMSON REUTERS
·
Aug 20

Piper Sandler Adjusts Price Target on Moderna to $167 From $77, Maintains Overweight Rating

MT Newswires Live
·
Aug 20

BofA Securities Upgrades Moderna to Neutral From Underperform Following Intismeran 'Success', Raises Price Target to $170 From $40

MT Newswires Live
·
Aug 20

Twist Bioscience Shares Rise After Selection by Anthropic to Evaluate Protein Design Project

MT Newswires Live
·
Aug 20

Asia Morning Call-Global Markets

Reuters
·
Aug 20